FUJIFILM Medical Systems U.S.A., Inc., a leading provider of diagnostic imaging and medical informatics solutions, recently expanded its breast imaging solutions with the launch of its Tomosynthesis Biopsy option for the ASPIRE Cristalle mammography system. 

The Department of Energy (DOE)’s National Nuclear Security Administration has awarded cooperative agreements for the production of molybdenum-99 (Mo-99) to three U.S. companies, including NorthStar Medical Radioisotopes.

Researchers have developed a convolutional neural network (CNN) that predicts long-term mortality from a single chest x-ray, according to new findings published in JAMA Network Open. 

State-level breast density reporting legislation is not associated with any significant changes in ultrasound utilization, according to new findings published in the Journal of the American College of Radiology.

After looking at more than 12,500 preventative office visits included in the National Ambulatory Medical Care Survey, researchers reported that the rate of screening breast ultrasound ordering by physicians has remained low.

Industry leaders, including the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the Medical Imaging and Technology Alliance (MITA), hosted a Capitol Hill Briefing July 17, to discuss a bipartisan bill that would expand patient access to diagnostic radiopharmaceuticals.

The updated LR-5 criteria for Liver Imaging Reporting and Data System (LI-RADS) version 2018 can improve sensitivity for diagnosing small hepatocellular carcinomas (HCC) compared to LI-RADS 2017.

NorthStar Medical Radioisotopes has finished construction of its new molybdenum-99 (Mo-99) processing facility in Beloit, Wisconsin, the company announced on July 16.